Showing results (31-40 of 301) with videos related to
Sort By:
Pageof 31
Frontiers in Immunology|March 16, 2026
The natural human adaptive IgG-specific immune response is skewed towards non-protective tail domains of DNABII proteinsKathryn Q Wilbanks, Jaime D Rhodes, Steven D Goodman, et al.Annals of the American Thoracic Society|April 4, 2018
Early Hospital Readmissions after an Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Nationwide Readmissions DatabaseDavid M Jacobs, Katia Noyes, Jiwei Zhao, et al.The Journal of Infectious Diseases|August 19, 2007
Serum antipneumococcal antibodies and pneumococcal colonization in adults with chronic obstructive pulmonary diseaseRichard Malley, Marc Lipsitch, Debby Bogaert, et al.Antimicrobial Agents and Chemotherapy|May 4, 2016
Effect of Fluoroquinolones and Macrolides on Eradication and Resistance of Haemophilus influenzae in Chronic Obstructive Pulmonary DiseaseMelinda M Pettigrew, Brian T Tsuji, Janneane F Gent, et al.Antimicrobial Agents and Chemotherapy|November 29, 2017
Azithromycin Pharmacodynamics against Persistent Haemophilus influenzae in Chronic Obstructive Pulmonary DiseaseBrian T Tsuji, James Fisher, Raheal Boadi-Yeboah, et al.Infection and Immunity|August 6, 2008
Serial isolates of persistent Haemophilus influenzae in patients with chronic obstructive pulmonary disease express diminishing quantities of the HMW1 and HMW2 adhesinsDeborah M Cholon, David Cutter, Stephen K Richardson, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2005
Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary diseaseSanjay SethiExpert Opinion on Pharmacotherapy|October 3, 2003
Gatifloxacin in community-acquired respiratory tract infectionSanjay SethiCurrent Opinion in Infectious Diseases|March 17, 2004
New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary diseaseSanjay SethiBMC Medicine|October 14, 2008
The problems of meta-analysis for antibiotic treatment of chronic obstructive pulmonary disease, a heterogeneous disease: a commentary on Puhan et alSanjay SethiPageof 31